Pharmaniaga skids on govt plan to focus on Pfizer


A health worker displays the Covid-19 vaccines developed by China's Sinovac. - Xinhua

KUALA LUMPUR: Shares of Pharmaniaga fell to a low of 88.5 sen on Friday after the government said states will begin dispensing more Pfizer-BioNTech vaccines over Sinovac.

Pharmaniaga has the contract to deliver the Sinovac vaccines and the latest statement worried investors as it had plans to expand the output of the China vaccine later.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Pharmaniaga , Sinovac , Pfizer

Next In Business News

Chipmakers driving AI boom
Nationgate says IRB investigation completed, records in order
CIMB upgraded to AAA in MSCI ESG ratings on stronger sustainability practices
Poultry farmer Hock Soon Capital seeks to raise RM60mil from IPO
Bursa Malaysia continues uptrend at midday
AMS Advanced Material gets Bursa Malaysia's nod for ACE Market listing
Malaysia Airports strengthens China connectivity at KLIA, Tawau to support VM2026
HSS Engineers' associate secures RM22mil EPCC consulting job for data centre in Perak
Oil edges up after Trump backs off tariff threat on Greenland
Guan Huat Seng opens slightly lower at 24 sen in ACE Market debut

Others Also Read